Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Consumer & Luxury

Sleep Number Appoints New Finance Chief Amid Strategic Overhaul

Robert Sasse by Robert Sasse
December 5, 2025
in Consumer & Luxury, Earnings, Turnaround
0
Sleep Number Stock
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

Smart bed manufacturer Sleep Number has named Amy O’Keefe as its new Chief Financial Officer, effective Monday, December 8. The leadership change coincides with a reaffirmation of the company’s full-year 2025 financial outlook, a move interpreted by the market as a sign of stability during an ongoing corporate transformation. Shares in the company responded positively to the dual announcement, climbing nearly 2% in initial trading.

Financial Outlook Maintained

Despite a challenging operating environment, Sleep Number’s management has chosen to stand by its previously stated financial targets for 2025. This confirmation comes just weeks after the company revised its revenue projection downward in November. The reiterated guidance includes the following key metrics:
* Net sales of approximately $1.4 billion
* A gross profit margin near 60%
* Adjusted EBITDA of about $70 million
* Negative free cash flow of roughly $50 million

The decision to uphold these figures suggests the executive team retains confidence in its current stabilization plan, even after the recent sales forecast adjustment from an initial $1.45 billion.

Incoming CFO Brings Deep Transformation Experience

Amy O’Keefe assumes the CFO role with over three decades of experience guiding operational and financial turnarounds, primarily within the consumer goods and technology industries. She joins Sleep Number from Avaya, where she served as Chief Financial and Administrative Officer and played a key role in enhancing the firm’s free cash flow. Her prior executive experience includes holding the top finance position at both Weight Watchers International and Savant Systems.

Should investors sell immediately? Or is it worth buying Sleep Number?

She will succeed interim CFO Bob Ryder, who will support the transition through December 12. O’Keefe’s appointment represents a continuation of the strategic repositioning initiated under CEO Linda Findley. This year alone, Sleep Number has executed extensive restructuring efforts, incurring costs totaling $47.5 million.

Stock Performance and Analyst Sentiment

Sleep Number’s equity has experienced significant volatility following a difficult year, having lost more than 60% of its value over the past twelve months. However, the stock has managed to post modest gains in recent weeks. The current average analyst rating on the shares is “Hold.”

The company’s leadership is scheduled to provide further strategic details at several upcoming investor conferences. The market will be watching closely for insights into how the new financial leadership plans to navigate the company’s path back to sustainable growth and profitability.

Ad

Sleep Number Stock: Buy or Sell?! New Sleep Number Analysis from February 7 delivers the answer:

The latest Sleep Number figures speak for themselves: Urgent action needed for Sleep Number investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Sleep Number: Buy or sell? Read more here...

Tags: Sleep Number
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock
Consumer & Luxury

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Next Post
Bloom Energy Stock

Fueling the AI Revolution: Bloom Energy Shares Surge on Data Center Demand

Apple Stock

Leadership Shifts at Apple Spark Investor Scrutiny Amid Strong Fundamentals

Uranium Energy Stock

A Major Vote of Confidence: Norway's Sovereign Fund Takes a Stake in Uranium Energy

Recommended

Fiserv Stock

Fiserv Shares Struggle to Gain Traction Amid Investor Doubts

3 weeks ago
Cooper-Standard Stock

Cooper-Standard Shares Plunge on Disappointing Earnings Report

3 months ago
Volatus Aerospace Stock

Volatus Aerospace Expands Defense and Environmental Technology Operations

5 months ago
FCBC stock news

Symmetry Partners LLC Acquires Significant Position in Carnival Co. & plc, Expresses Optimism for Future Growth

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Trending

Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

by Rodolfo Hanigan
February 7, 2026
0

Medical device company Embecta reported financial results for the first quarter of fiscal year 2026 on Thursday,...

Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Embecta’s Q1 Performance Outpaces Analyst Forecasts
  • Camping World’s New Leadership Faces First Major Test
  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com